Mirafuentes, Luzminda .
HRN: 26-28-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2024
CEFUROXIME 500MG (TAB)
11/28/2024
12/05/2024
ORAL
500mg
BID
S/P LSTCS + BTL
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes